TipRanks
InVitro International (IVRO)
OTHER OTC:IVRO
US Market

InVitro International (IVRO) Ratios

4 Followers

InVitro International Ratios

IVRO's free cash flow for Q3 2026 was $0.82. For the 2026 fiscal year, IVRO's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
11.56 12.18 16.69 18.57 21.68
Quick Ratio
10.18 10.71 14.73 16.51 19.37
Cash Ratio
9.38 5.35 4.44 4.52 18.06
Solvency Ratio
0.24 0.37 0.29 0.07 0.37
Operating Cash Flow Ratio
0.03 -0.06 1.05 -0.75 0.60
Short-Term Operating Cash Flow Coverage
0.06 -0.12 1.87 0.00 0.00
Net Current Asset Value
$ 1.21M$ 1.17M$ 1.19M$ 1.39M$ 1.41M
Leverage Ratios
Debt-to-Assets Ratio
0.12 0.14 0.17 0.03 0.00
Debt-to-Equity Ratio
0.14 0.17 0.22 0.03 0.00
Debt-to-Capital Ratio
0.12 0.15 0.18 0.03 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.21 1.24 1.05 1.05
Debt Service Coverage Ratio
0.73 2.02 2.12 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.05 0.05 0.02 0.00 0.00
Interest Debt Per Share
0.01 0.01 0.02 <0.01 0.00
Net Debt to EBITDA
-18.49 -2.92 -0.69 -46.88 -74.89
Profitability Margins
Gross Profit Margin
81.88%81.70%80.55%80.24%79.69%
EBIT Margin
5.61%14.07%13.15%0.30%1.47%
EBITDA Margin
6.91%14.73%13.81%0.84%1.93%
Operating Profit Margin
4.45%9.90%8.42%-3.20%-13.68%
Pretax Profit Margin
8.51%14.07%13.15%0.30%1.47%
Net Profit Margin
8.18%13.88%13.15%0.20%2.49%
Continuous Operations Profit Margin
8.18%13.88%13.15%0.20%2.49%
Net Income Per EBT
96.06%98.66%100.00%66.00%169.31%
EBT Per EBIT
191.18%142.08%156.23%-9.29%-10.76%
Return on Assets (ROA)
3.16%6.09%5.47%0.10%1.41%
Return on Equity (ROE)
3.76%7.37%6.81%0.11%1.48%
Return on Capital Employed (ROCE)
1.84%4.63%3.68%-1.74%-8.10%
Return on Invested Capital (ROIC)
1.70%4.42%3.58%-1.12%-8.10%
Return on Tangible Assets
3.17%6.12%5.49%0.10%1.42%
Earnings Yield
4.74%8.99%4.71%0.12%1.44%
Efficiency Ratios
Receivables Turnover
10.35 14.81 13.21 8.20 16.59
Payables Turnover
33.46 42.79 136.03 19.48 33.20
Inventory Turnover
0.78 0.88 0.86 0.96 1.10
Fixed Asset Turnover
3.33 3.10 2.32 14.62 57.23
Asset Turnover
0.39 0.44 0.42 0.52 0.57
Working Capital Turnover Ratio
0.56 0.61 0.57 0.57 0.61
Cash Conversion Cycle
492.37 431.42 449.60 405.88 342.72
Days of Sales Outstanding
35.28 24.64 27.64 44.49 22.00
Days of Inventory Outstanding
468.00 415.31 424.64 380.13 331.72
Days of Payables Outstanding
10.91 8.53 2.68 18.74 11.00
Operating Cycle
503.28 439.95 452.28 424.62 353.72
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 >-0.01 <0.01 >-0.01 <0.01
Free Cash Flow Per Share
>-0.01 >-0.01 <0.01 >-0.01 <0.01
CapEx Per Share
<0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
-0.03 1.19 1.00 1.01 0.77
Dividend Paid and CapEx Coverage Ratio
0.97 -5.22 0.00 -69.54 4.33
Capital Expenditure Coverage Ratio
0.97 -5.22 0.00 -69.54 4.33
Operating Cash Flow Coverage Ratio
0.02 -0.03 0.29 -1.35 0.00
Operating Cash Flow to Sales Ratio
<0.01 >-0.01 0.12 -0.07 0.05
Free Cash Flow Yield
>-0.01%-0.64%4.35%-4.60%2.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.14 11.11 21.24 838.98 69.23
Price-to-Sales (P/S) Ratio
1.73 1.54 2.79 1.64 1.73
Price-to-Book (P/B) Ratio
0.78 0.82 1.45 0.90 1.02
Price-to-Free Cash Flow (P/FCF) Ratio
-12.14K -156.26 22.98 -21.73 47.13
Price-to-Operating Cash Flow Ratio
326.76 -186.23 22.98 -22.04 36.26
Price-to-Earnings Growth (PEG) Ratio
-0.50 0.75 <0.01 -9.44 -0.88
Price-to-Fair Value
0.78 0.82 1.45 0.90 1.02
Enterprise Value Multiple
6.57 7.56 19.54 148.17 14.61
Enterprise Value
350.32K 978.38K 2.19M 989.80K 240.41K
EV to EBITDA
6.57 7.56 19.54 148.17 14.61
EV to Sales
0.45 1.11 2.70 1.25 0.28
EV to Free Cash Flow
-3.18K -112.72 22.20 -16.51 7.69
EV to Operating Cash Flow
86.10 -134.34 22.20 -16.74 5.92
Tangible Book Value Per Share
0.08 0.07 0.07 0.06 0.06
Shareholders’ Equity Per Share
0.08 0.07 0.07 0.06 0.06
Tax and Other Ratios
Effective Tax Rate
0.04 0.01 0.00 0.34 -0.69
Revenue Per Share
0.03 0.04 0.04 0.03 0.04
Net Income Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Tax Burden
0.96 0.99 1.00 0.66 1.69
Interest Burden
1.52 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.06 0.05 0.07 0.02 0.10
SG&A to Revenue
0.71 0.67 0.65 0.79 0.74
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.01 <0.01
Income Quality
0.06 -0.06 0.92 -38.06 1.91
Currency in USD